BLUEBIRD STRATEGIES

Lobbying for MYOTONIC · Patient advocacy organization.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · posted Jan 21, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Funding for myotonic dystrophy research as part of the FY26 Congressionally Directed Medical Research Program

Budget/Appropriations

Myotonic dystrophy biomedical research funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.